PMID: 1191416Oct 1, 1975Paper

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

British Heart Journal
F WaagsteinI Wallentin


Adrenergic beta-blocking agents were given to 7 patients with advanced congestive cardiomyopathy who had tachycardia at rest (98 plus or minus 13 beats/min). The patients were on beta-adrenergic receptor blockade for 2 to 12 months (average 5-4 months). One patient was given alprenolol 50 mg twice daily and the other patients were given practolol 50 to 400 mg twice daily. Virus infection had occurred in 6 of the patients before the onset of symptoms of cardiac disease. All patients were in a steady state or were progressively deteriorating at the start of beta-adrenergic receptor blockade. Conventional treatment with digitalis and diuretics was unaltered or reduced during treatment with beta-blocking agents. An improvement was seen in their clinical condition shortly after administration of the drugs. Continued treatment resulted in an increase in physical working capacity and a reduction of heart size. Noninvasive investigations including phonocardiogram, carotid pulse curve, apex cardiogram, and echocardiogram showed improved ventricular function in all cases. The present study indicates that adrenergic beta-blocking agents can improve heart function in at lease some patients with congestive cardiomyopathy. Furthermore, it is...Continue Reading


Aug 1, 1974·Circulation·J F Goodwin
Jan 31, 1969·Annals of the New York Academy of Sciences·E BajuszF Homburger
Apr 1, 1971·The American Journal of Cardiology·E Braunwald
Jun 1, 1972·British Heart Journal·J F Goodwin, C M Oakley
Jan 1, 1972·The American Journal of Medicine·C D McDonaldJ J Walsh
Mar 1, 1972·American Heart Journal·D W Romhilt, R C Scott
Apr 1, 1971·Circulation·J F PomboR O Russell
Sep 1, 1968·British Heart Journal·E J EpsteinN G Doukas
Jul 1, 1969·American Heart Journal·T HirataH Feigenbaum
May 1, 1958·Circulation Research·E BRAUNWALDW N STAINSBY
May 1, 1965·The American Journal of Cardiology·J C RIOS, R A MASSUMI
Jan 1, 1948·The American Journal of Medicine·J E DEITRICKE SHORR

❮ Previous
Next ❯


Sep 1, 1992·Clinical Cardiology·N K Wenger
May 1, 1993·Clinical Cardiology·N L Weintraub, B R Chaitman
Sep 1, 1995·Clinical Cardiology·A M FeldmanS Murali
Dec 16, 1998·Clinical Cardiology·M R BristowE J Eichhorn
Feb 1, 1992·Cardiovascular Drugs and Therapy·C Kawai
Jan 1, 1996·Revue médicale de Liège·H Kulbertus
Feb 1, 1994·Cardiovascular Drugs and Therapy·Y KogaK Kajiyama
May 1, 1994·Cardiovascular Drugs and Therapy·H PouleurM F Rousseau
Apr 1, 1995·Cardiovascular Drugs and Therapy·V PanfilovG Olsson
Jan 1, 1991·Heart and Vessels. Supplement·A MatsumoriS Nobuoka
Jan 1, 1991·Heart and Vessels. Supplement·E M GilbertM R Bristow
Jun 1, 1990·Cardiovascular Drugs and Therapy·N Rehnqvist
Apr 1, 1990·Cardiovascular Drugs and Therapy·A V MattioliG Mattioli
Jan 1, 1994·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·R S BeanlandsM Schwaiger
Jun 8, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M D CarcelesM L Laorden
Jun 1, 1991·Cardiovascular Drugs and Therapy·H Persson, L Erhardt
Feb 14, 1998·Annals of Nuclear Medicine·H YamanariT Ohe
Sep 14, 1999·Heart and Vessels·M Kitakaze, M Hori
May 8, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Finn Olav Levy
Sep 12, 2006·European Journal of Clinical Pharmacology·H KnaufE Mutschler
Nov 21, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·W Doehner, S D Anker
Jun 11, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Hans-Dirk DüngenUNKNOWN CIBIS-ELD Investigators, Subproject Multicenter Trials in the Competence Network Heart Failure
Jul 23, 2005·Current Heart Failure Reports·Steven R Goldsmith
Nov 7, 2001·Current Treatment Options in Cardiovascular Medicine·Kenneth L. Baughman
Oct 22, 2004·Current Treatment Options in Cardiovascular Medicine·Allison M Pritchett, Douglas L Mann
Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·S S Gottlieb
Jan 1, 2003·Comprehensive Therapy·Ravi K GargAllen S Anderson
Jan 1, 1983·Pharmacology & Therapeutics·W H Newman
Jan 1, 1995·Archives of Gerontology and Geriatrics·L QuattriniE Paciaroni
May 1, 1989·Journal of the American College of Cardiology·W H Abelmann, B H Lorell
Oct 1, 1991·Journal of the American College of Cardiology·M Jessup
Apr 1, 1993·Journal of the American College of Cardiology·T WisenbaughP Sareli
May 1, 1994·Journal of the American College of Cardiology·B AnderssonF Waagstein
Mar 15, 1994·Journal of the American College of Cardiology·M L FisherB P Hamilton
Mar 1, 1994·Journal of the American College of Cardiology·R N DoughtyN Sharpe
May 1, 1995·Journal of the American College of Cardiology·S L OlsenM R Bristow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.